OPV Cessation--the Final Step To a "Polio-Free" World
- 28 October 2005
- journal article
- policy forum
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 310 (5748), 625-626
- https://doi.org/10.1126/science.1115547
Abstract
The 20-year, U.S. $4 billion-dollar international effort to eradicate wild polioviruses now includes monovalent oral poliovirus type 1 vaccine (mOPV1), which was first given to 40 million children in India in April 2005. As this vaccine is being introduced to eliminate some of the last poliovirus reservoirs, the Global Polio Eradication Initiative is planning for the eventual synchronized worldwide cessation of the routine use of all oral poliovirus vaccines (OPVs) because of their capacity to cause, rarely, outbreaks of paralytic poliomyelitis. This Policy Forum reviews the feasibility and implications of eventually stopping the use of live polio vaccines.Keywords
This publication has 12 references indexed in Scilit:
- A Dynamic Model of Poliomyelitis Outbreaks: Learning from the Past to Help Inform the FutureAmerican Journal of Epidemiology, 2005
- A global call for new polio vaccinesNature, 2005
- Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001Journal of Virology, 2004
- Getting Polio Eradication Back on Track in NigeriaNew England Journal of Medicine, 2004
- Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 1983 to 1993Journal of Virology, 2003
- Recombinant Vaccine–Derived Poliovirus in MadagascarEmerging Infectious Diseases, 2003
- Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived PoliovirusScience, 2002
- Public Health Assessment of Potential Biological Terrorism AgentsEmerging Infectious Diseases, 2002
- "Endgame" Issues for the Global Polio Eradication InitiativeClinical Infectious Diseases, 2002
- Recent Events and Observations Pertaining to Smallpox Virus Destruction in 2002Clinical Infectious Diseases, 2001